SastiMedic
Cisplan-10mg Inj.

Cisplan-10mg Inj.

MRP: ₹94.54

Packaging

1 INJECTION

Composition

Cisplatin 10mg

Company

Natco Pharma

Buy Now

Substitutes for Cisplan-10mg Inj.

Medicine Company Price You Save
Platinex-10mg Inj. Khandelwal ₹75.00 Save ₹19.54
Cisteen-10mg Inj. Miracauls ₹82.00 Save ₹12.54
Platicis 10mg Inj. Zydus Cadila ₹86.70 Save ₹7.84
Oncoplatin-AQ-10mg Inj. Sun Pharma ₹87.50 Save ₹7.04
Cytoplatin 10 mg Injecction Cipla ₹94.64
Platikem-10mg Inj. Alkem Labs ₹96.30
Uniplatin 10mg Inj. United Biotech ₹126.00
Blastolem-10mg Inj. Elder Pharma ₹164.16

Side Effects of Cisplan-10mg Inj.

Severe nausea and vomiting. Serious toxic effects on the kidneys, bone marrows and ears. Hypomagnesaemia, hypocalcaemia, hyperuricaemia. Peripheral neuropathies, papilloedema, optic neuritis, seizures. Ototoxicity (children) manifested as tinnitus, loss of hearing, deafness or vestibular toxicity. Potentially Fatal: Rarely, renal damage due to inadequate hydration during therapy. Very rarely life-threatening myelosuppression. Anaphylactoid reactions (rare) and cardiac abnormalities.

Drug Interactions

Synergistic with 5-fluorouracil and etoposide. Efficacy increased and toxicity reduced when combined with radioprotecting agent WR 2721. At doses ≤100 mg, cisplatin is an ideal drug to combine with other cytotoxic drugs; unlike other antineoplastic drugs, it causes little myelosuppression. Potentially Fatal: Potentiates nephrotoxicity with aminoglycosides. Increased toxicity when combined with other cytotoxic drugs.

Contraindications

Patients with severe renal or auditory disorder, known hypersensitivity, severe bone marrow suppression, peripheral neuropathy, pregnancy, lactation.

Mechanism of Action

Cisplatin modifies cell cycle by interfering with DNA structure and function. Effects are most prominent during the S phase but cells are killed at all stages. Cisplatin synergises with other anticancer drugs e.g. fluorouracil. It has a narrow therapeutic margin and is highly toxic. Absorption: Well absorbed (intraperitoneal). Distribution: Concentrated in the liver, kidneys, large and small intestines; poor penetration into the CNS. Excretion: Urine. Elimination half-life: 25-49 min (initial), 58-73 hr (terminal).

Special Precautions

Patients with renal or hepatic disorder, myelosuppression. Monitor renal, neurological and auditory function. Perform blood counts regularly. Maintain adequate hydration before and 24 hr after admin to minimise nephrotoxicity.

How to Use

Take orally with food and water, as directed by your physician.

How to Store

Keep in a cool, dry place away from sunlight and moisture.

Safety Concerns

  • Alcohol: Avoid during treatment.
  • Breastfeeding: Not recommended.
  • Pregnancy: Contraindicated.
  • Liver/Kidney: Use with caution.

Content Disclaimer

This content is for educational purposes only. Please consult your doctor before use.

More brands by Natco Pharma

Written by: SastiMedic Medical Team

Reviewed by: Registered Pharmacist